As drug and device manufacturers continue to await final federal rules implementing the Affordable Care Act’s Physician Payment Sunshine Act (“Sunshine Act”) provisions, Massachusetts has relaxed its similar state law banning the provision by manufacturers of gifts to health care practitioners (HCPs) and requiring disclosure of payments and transfers of value to HCPs. The revisions are intended to loosen certain restrictions on providing meals and other expenses to HCPs, and relieve manufacturers of the duty to report to Massachusetts information that has been disclosed to federal agencies, such as data reported to CMS under the Sunshine Act. Massachusetts also will permit pharmaceutical manufacturers to offer drug coupons to Massachusetts residents if certain conditions are met. Additional information is available on Reed Smith’s Life Sciences Legal Update.